Invention Application
- Patent Title: PYRIDAZINE DERIVATIVES AS RORc MODULATORS
-
Application No.: US15801178Application Date: 2017-11-01
-
Publication No.: US20180051010A1Publication Date: 2018-02-22
- Inventor: Benjamin Fauber , Monique Bodil van Niel , Andrew Cridland , Christopher Hurley , Jonathan Killen , Stuart Ward , Paul Winship
- Applicant: Genentech, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D403/14 ; C07D401/14 ; C07D401/12 ; C07D237/26 ; C07D487/04 ; C07D471/04 ; C07D413/14 ; C07D413/04
Abstract:
Compounds of formula I: or pharmaceutical salts thereof, wherein R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.
Public/Granted literature
- US09994551B2 Pyridazine derivatives as RORc modulators Public/Granted day:2018-06-12
Information query
